Health ministry tightens rules for antimicrobial drug approvals
By News Desk··~1 min read
India's health authority is moving to impose tougher controls on antimicrobial drugs. Under the proposed change, manufacturers must now secure Central approval before seeking state licensing—a step designed to prevent substandard medicines from reaching patients.
The amendment targets gaps where licences were granted without proper testing for bioavailability, stability and efficacy. Poor-quality antimicrobials accelerate drug resistance, a growing global threat. The government is seeking public feedback on the draft rules before moving forward with implementation.